Patents by Inventor Ryland Young

Ryland Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sensing phage-triggered ion cascade (SEPTIC)
    Patent number: 7229754
    Abstract: The present invention provides a method for detecting bacteria and a nano-well device having one or more input/output connections about a gap and one or more bacteriophages at or about the gap that trigger a detectable electrical field fluctuation when the one or more bacteriophages contact a cognate target within a liquid sample.
    Type: Grant
    Filed: November 23, 2005
    Date of Patent: June 12, 2007
    Inventors: Laszlo B. Kish, Maria Dobozi-King, Ryland Young, Mosong Cheng, James R. Biard, Sergey Bezrukov
  • SENSING PHAGE-TRIGGERED ION CASCADE (SEPTIC)
    Publication number: 20070111220
    Abstract: The present invention provides a method for detecting bacteria and a nano-well device having one or more input/output connections about a gap and one or more bacteriophages at or about the gap that trigger a detectable electrical field fluctuation when the one or more bacteriophages contact a cognate target within a liquid sample.
    Type: Application
    Filed: November 23, 2005
    Publication date: May 17, 2007
    Applicant: The Texas A&M University System
    Inventors: Laszlo Kish, Maria Dobozi-King, Ryland Young, Mosong Cheng, James Biard, Sergey Bezrukov
  • Antibiotics based upon bacteriophage lysis proteins
    Publication number: 20050191628
    Abstract: This invention relates to polypeptide antibiotics, including materials and methods related thereto, based upon the observation that bacteriophage elaborate proteins that cause host cell lysis by interfering with specific steps in cell wall biosynthesis. Examples of antibiotics based upon this invention include the bacteriophage ?X174 gene E product and structurally and/or functionally related polypeptide and small protein antibiotics that interact with MraY, and the bacteriophage Q? gene A2 product and structurally and/or functionally related polypeptide and small protein antibiotics that interact with MurA. This leads to the general model for obtaining new polypeptide antibiotics by using genetic approaches based on these findings to find polypeptide sequences which cause bacterial cell lysis.
    Type: Application
    Filed: July 23, 2003
    Publication date: September 1, 2005
    Inventors: Ryland Young, William Roof, Douglas Struck, Thomas Bernhardt, Ing-Nang Wang